Natural Products as Modulators of Sirtuins

• Published in: Molecules (Basel, Switzerland) Vol. 25; no. 14; p. 3287
• Main Authors: Karaman Mayack, Berin, Sippl, Wolfgang, Ntie-Kang, Fidele
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 20-07-2020; MDPI
• Subjects: Aging; Aging (natural); Alzheimer's disease; Animals; Binding sites; Biological Products - chemistry; Biological Products - pharmacology; Chemical compounds; Chemistry; Clinical trials; Diabetes mellitus; Drug development; Drug Discovery; Drugs; Enzymes; epigenetics; Genomes; High-throughput screening; Humans; Library collections; Medical treatment; Metabolites; Models, Molecular; Molecular Targeted Therapy; Natural products; Natural resources; NMR; Nuclear magnetic resonance; Pharmaceutical industry; Productivity; Proteins; Review; sirtuin; Sirtuins; Sirtuins - antagonists & inhibitors; Sirtuins - chemistry; Sirtuins - metabolism; structure–activity relationship; Therapeutic applications; structure–activity relationship; natural products; drug discovery; sirtuin; epigenetics
• ISSN: 1420-3049; 1420-3049
• DOI: 10.3390/molecules25143287

Natural products have been used for the treatment of human diseases since ancient history. Over time, due to the lack of precise tools and techniques for the separation, purification, and structural elucidation of active constituents in natural resources there has been a decline in financial support and efforts in characterization of natural products. Advances in the design of chemical compounds and the understanding of their functions is of pharmacological importance for the biomedical field. However, natural products regained attention as sources of novel drug candidates upon recent developments and progress in technology. Natural compounds were shown to bear an inherent ability to bind to biomacromolecules and cover an unparalleled chemical space in comparison to most libraries used for high-throughput screening. Thus, natural products hold a great potential for the drug discovery of new scaffolds for therapeutic targets such as sirtuins. Sirtuins are Class III histone deacetylases that have been linked to many diseases such as Parkinson`s disease, Alzheimer's disease, type II diabetes, and cancer linked to aging. In this review, we examine the revitalization of interest in natural products for drug discovery and discuss natural product modulators of sirtuins that could serve as a starting point for the development of isoform selective and highly potent drug-like compounds, as well as the potential application of naturally occurring sirtuin inhibitors in human health and those in clinical trials.